60 Degrees PharmaceuticalsSXTP
About: 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
Employees: 2
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 [Q1] → 10 (+2) [Q2]
1.43% less ownership
Funds ownership: 4.38% [Q1] → 2.96% (-1.43%) [Q2]
29% less capital invested
Capital invested by funds: $127K [Q1] → $90.1K (-$36.5K) [Q2]
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Research analyst outlook
We haven’t received any recent analyst ratings for SXTP.